UNIVERSITY OF ILLINOIS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1859-01-01

Employees: 10K

Market Cap: -

Website: http://www.illinois.edu

Clinical Trials

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Not Applicable

Not yet recruiting

Conditions: End Stage Renal Disease on Dialysis

First Posted Date: 2025-06-10

Last Posted Date: 2025-06-10

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 40

Registration Number: NCT07014111

Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function

Not Applicable

Not yet recruiting

Conditions: Stroke

First Posted Date: 2025-06-05

Last Posted Date: 2025-06-08

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 50

Registration Number: NCT07006818

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Ischemic Preconditioning in Osteoarthritis and Back Pain

Not Applicable

Not yet recruiting

Conditions: Low Back Pain
Knee Osteoarthritis

First Posted Date: 2025-06-04

Last Posted Date: 2025-06-04

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 24

Registration Number: NCT07003113

Locations: 🇺🇸
Human and Sport Performance Lab, Chicago, Illinois, United States

Testing the Effectiveness and Implementation of a Meditation App for Youth in the Legal System

Not Applicable

Recruiting

Conditions: Behavioral Health

First Posted Date: 2025-05-30

Last Posted Date: 2025-06-11

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 300

Registration Number: NCT06997120

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

Enhancing Diabetes Care: Exposome &Amp; Sensors

Recruiting

Conditions: Type 2 Diabetes

First Posted Date: 2025-05-25

Last Posted Date: 2025-05-25

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 20

Registration Number: NCT06989008

Locations: 🇺🇸
University of Illinois - Chicago, Chicago, Illinois, United States
🇺🇸
University of Illinois College of Nursing, Chicago, Illinois, United States

Sickle Cell, Pain and Mediterranean Diet

Not Applicable

Not yet recruiting

Conditions: Sickle Cell
Mediterranean Diet
Sickle Cell Disease
Sickle Cell Disease Without Crisis

First Posted Date: 2025-03-25

Last Posted Date: 2025-03-27

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 30

Registration Number: NCT06886477

Site-randomized Trial of an Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

Not Applicable

Not yet recruiting

Conditions: Undiagnosed HIV Infection
Populations That Are Reluctant to Test for HIV
Long-term Undiagnosed HIV Infection
Individuals With Newly-diagnosed HIV Infection
HIV-related Stigma
Access to HIV Testing

First Posted Date: 2025-03-04

Last Posted Date: 2025-03-04

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 2480

Registration Number: NCT06857071

Locations: 🇿🇦
Centre for Community-based Research, Human Sciences Research Council, Pietermaritzburg, KwaZulu-Natal, South Africa

Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions

Not Applicable

Not yet recruiting

Conditions: Opioid Overdose Prevention
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Reduction of Substance Use-related Stigma
Non-substance-using People With a Friend or Family Member Who Uses Opioids
Peer Harm Reduction Support Champions

First Posted Date: 2025-02-12

Last Posted Date: 2025-02-12

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 600

Registration Number: NCT06823453

Locations: 🇺🇸
Community Outreach Intervention Projects (COIP), Chicago, Illinois, United States

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia, Relapsed, Adult
Acute Myeloid Leukemia Refractory
Chronic Myeloid Leukemia - Accelerated Phase
Myelodysplastic Syndromes

Interventions: Radiation: Intensity modulated total marrow irradiation
Drug: Cyclophosphamide (CTX)
Drug: Fludarabine (Fludara)
Drug: Busulfan (conditioning for ALLO Transplant)

First Posted Date: 2025-01-31

Last Posted Date: 2025-06-25

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 38

Registration Number: NCT06802315

Locations: 🇺🇸
University of Illinois Cancer Center, Chicago, Illinois, United States

Research Investigating Drug Effects-2 (RiDE-2)

Early Phase 1

Not yet recruiting

Conditions: Cannabis Use
Healthy
Substance Use Disorder (SUD)

Interventions: Drug: Placebo Oral Capsule
Drug: THC

First Posted Date: 2025-01-06

Last Posted Date: 2025-01-06

Lead Sponsor: University of Illinois at Chicago

Target Recruit Count: 144

Registration Number: NCT06758596

Locations: 🇺🇸
University of Illinois at Chicago, Chicago, Illinois, United States

AI-Powered Research

Premium Access

UNIVERSITY OF ILLINOIS

Fight Fatigue: A Progressive Muscle Relaxation and Walking Intervention to Reduce Fatigue in Adults With ESKD

Impaired Interlimb Coordination During Locomotion in Individuals With Chronic Stroke: Contributors and Effect on Walking Function

Ischemic Preconditioning in Osteoarthritis and Back Pain

Testing the Effectiveness and Implementation of a Meditation App for Youth in the Legal System

Enhancing Diabetes Care: Exposome &Amp; Sensors

Sickle Cell, Pain and Mediterranean Diet

Site-randomized Trial of an Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-related Stigma

Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions

Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

Research Investigating Drug Effects-2 (RiDE-2)